| Literature DB >> 31787342 |
Dane Huang1, Xiangkun Luo1, Zhiyong Yin1, Jun Xu2, Qiong Gu3.
Abstract
Compounds 1-11 were isolated from the aerial parts of Flueggea acicularis Croizz Webster, including three new rearranged clesistanthane diterpenoids fluacinoids A-C (1-3) and five new norditerpenoid fluacinoids D-H (4-8). The new compounds were identified from spectroscopic data combined with single crystal X-ray diffraction analysis, modified Mosher's methods, and ECD data analyses. All the isolated compounds were evaluated for their activities on RANKL-induced osteoclastogenesis in bone marrow monocytes (BMMs). Compound 6 showed the most potent inhibition against osteoclast differentiation (IC50, 0.7 μM) and decreased the expression level of osteoclast-related genes. Moreover, compound 6 prompted the apoptosis of osteoclasts. Compound 6 also suppressed RANKL-induced NF-κB activation. This study reveals that norditerpenoids may be resource for anti-osteoporosis agents.Entities:
Keywords: Clesistanthane diterpenoids; Flueggea acicularis; Osteoclast; Osteoclastogenesis
Mesh:
Substances:
Year: 2019 PMID: 31787342 DOI: 10.1016/j.bioorg.2019.103453
Source DB: PubMed Journal: Bioorg Chem ISSN: 0045-2068 Impact factor: 5.275